Stock Events

Stock Events

Brainsway 

$14.66
28
-$0.83-5.36% Tuesday 20:00
+$0.00+0%Tuesday 20:00After hours

Statistics

Day High
14.69
Day Low
14.66
52W High
17.4
52W Low
7.14
Volume
3,551
Avg. Volume
-
Mkt Cap
588.32M
P/E Ratio
68.45
Dividend Yield
-
Dividend
-

Earnings

13AugExpected
Q4 2023
Q1 2024
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.03
-0
0.02
0.05
Expected EPS
0.05
Actual EPS
0.05

Financials

14.5%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
52.23MRevenue
7.58MNet Income

Analyst Ratings

18.60Average Price Target
The highest estimate is 20.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BWAY. It's not an investment recommendation.
Microsoft
6
MSFT
Realty Income
6
O
Amazon
5
AMZN
Coca-Cola
5
KO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap286.78B
Novartis offers treatments in neurology and mental health, competing in the broader market for mental health solutions.
Medtronic
MDT
Mkt Cap116.83B
Medtronic provides various medical devices, including those for neurological disorders, directly competing with Brainsway's deep TMS solutions.
Neogen
NEOG
Mkt Cap2.54B
NeuroOne Medical Technologies develops solutions for neurological disorders, potentially competing in the brain health space.
Abbvie
ABBV
Mkt Cap440.83B
AbbVie, through its acquisition of Allergan, has a portfolio of psychiatric medications, indirectly competing with Brainsway's non-drug approach.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson, through its subsidiary DePuy Synthes, offers neurosurgical products and has interests in mental health treatments.
Teamshares
TMS
Mkt Cap672.52M
TMS NeuroHealth Centers specialize in TMS therapy for depression, directly competing with Brainsway's core services.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.85B
Teva Pharmaceutical Industries offers generic and specialty medicines, including CNS treatments, competing in the broader mental health market.
LivaNova
LIVN
Mkt Cap4.53B
LivaNova operates in the neuromodulation space, offering therapies that could compete with Brainsway's TMS solutions.

About

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
Show more...
CEO
Hadar Levy
Employees
129
Country
Israel
ISIN
US10501L1061

Listings

OTC Link
US
BRSYF
XNAS
US
BWAY
TA
IL
BWAY.TA
BOATS
BOATS
BWAY.BOATS

0 Comments

Share your thoughts

FAQ

What is Brainsway stock price today?▼
The current price of BWAY is $14.66 USD — it has decreased by -5.36% in the past 24 hours. Watch Brainsway stock price performance more closely on the chart.
What is Brainsway stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Brainsway stocks are traded under the ticker BWAY.
Is Brainsway stock price growing?▼
BWAY stock has fallen by -11.69% compared to the previous week, the month change is a -6.8% fall, over the last year Brainsway has showed a +102.63% increase.
What is Brainsway market cap?▼
Today Brainsway has the market capitalization of 588.32M
What were Brainsway earnings last quarter?▼
BWAY earnings for the last quarter are 0.05 USD per share, whereas the estimation was 0.05 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Brainsway revenue for the last year?▼
Brainsway revenue for the last year amounts to 52.23M USD.
What is Brainsway net income for the last year?▼
BWAY net income for the last year is 7.58M USD.
How many employees does Brainsway have?▼
As of August 19, 2026, the company has 129 employees.
In which sector is Brainsway located?▼
Brainsway operates in the Health & Wellness sector.
When did Brainsway complete a stock split?▼
The last stock split for Brainsway was on March 03, 2026 with a ratio of 1:1.
Where is Brainsway headquartered?▼
Brainsway is headquartered in Jerusalem, Israel.